Stockscreener 앱 받기
1.97
9.63%
-0.21
시간 외 거래:
2.00
0.03
+1.52%
전일 마감가:
$2.18
열려 있는:
$2.2
하루 거래량:
401.40K
Relative Volume:
0.99
시가총액:
$38.27M
수익:
-
순이익/손실:
$-11.73M
주가수익비율:
-1.4249
EPS:
-1.3826
순현금흐름:
$-10.37M
1주 성능:
-23.35%
1개월 성능:
-34.11%
6개월 성능:
-29.64%
1년 성능:
+0.00%
1일 변동 폭
$1.93
$2.2273
1주일 범위
$1.93
$2.5881
52주 변동 폭
$1.80
$8.94
Medicus Pharma Ltd Stock (MDCX) Company Profile
명칭
Medicus Pharma Ltd
전화
610-540-7515
주소
300 CONSHOHOCKEN STATE RD., W. CONSHOHOCKEN
MDCX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MDCX
Medicus Pharma Ltd
|
1.97 | 38.27M | 0 | -11.73M | -10.37M | -1.3826 |
|
LLY
Lilly Eli Co
|
625.65 | 670.04B | 53.26B | 13.80B | -50.20M | 15.30 |
|
JNJ
Johnson Johnson
|
173.33 | 410.84B | 90.63B | 22.66B | 16.40B | 9.35 |
|
ABBV
Abbvie Inc
|
198.05 | 346.78B | 58.33B | 3.76B | 18.24B | 2.10 |
|
NVS
Novartis Ag Adr
|
116.84 | 219.72B | 55.19B | 13.65B | 16.81B | 6.86 |
|
MRK
Merck Co Inc
|
80.69 | 198.42B | 63.62B | 16.41B | 14.72B | 6.49 |
Medicus Pharma Ltd 주식(MDCX)의 최신 뉴스
Is Medicus Pharma Ltd. affected by consumer sentimentFree Breakout Stock Scanner - classian.co.kr
Published on: 2025-08-08 08:53:03 - beatles.ru
Medicus Pharma and HelixNano Partner to Develop Thermostable, Needle-Free mRNA Vaccines - AInvest
Medicus Pharma and HelixNano sign MOU to co-develop thermostable, needle-free mRNA vaccines - Proactive financial news
Medicus Pharma to acquire Antev - MSN
Candlestick Reversal Detected on Medicus Pharma Ltd.’s ChartTechnical Entry Strategy for Beginners Explained - metal.it
Medicus Pharma and HelixNano agree outline deal to develop heat-stable vaccines - Proactive financial news
Medicus Pharma LtdCo And Helixnano Enter MoU For Vaccine DevelopmentSEC Filing - TradingView
Medicus Pharma and HelixNano Announce Vaccine Collaboration - TipRanks
Medicus Pharma Ltd. Announces a Memorandum of Understanding (MOU) with Helix Nanotechnologies Inc. to Develop Thermostable Infectious Disease Vaccines - Newsfile
Bullish Candlestick Pattern Forms in Medicus Pharma Ltd.Investment Strategy With Predictable Gains Outlined - metal.it
The Biggest Takeaways From Boeing's Q2 Earnings Report - The Globe and Mail
Is it the right time to buy Medicus Pharma Ltd. stockTrack high-yield stocks before they peak - Jammu Links News
Helix Nanotechnologies - The Pharma Letter
What is the dividend policy of Medicus Pharma Ltd. stockBuild a portfolio that grows with the market - Jammu Links News
What makes Medicus Pharma Ltd. Equity Warrant stock price move sharplyFree Market Volatility Navigation Tips - Jammu Links News
When is Medicus Pharma Ltd. stock expected to show significant growthTurbocharged investment results - Jammu Links News
What analysts say about Medicus Pharma Ltd. stockNavigate market volatility with smart strategies - Jammu Links News
What are the technical indicators suggesting about Medicus Pharma Ltd. Equity WarrantGet expert analysis on top stock picks - Jammu Links News
What catalysts could drive Medicus Pharma Ltd. stock higher in 2025Build a portfolio for long-term financial success - Jammu Links News
How many analysts rate Medicus Pharma Ltd. Equity Warrant as a “Buy”Capitalize on fast-growing investment opportunities - Jammu Links News
How strong is Medicus Pharma Ltd. company’s balance sheetDiscover high-impact stocks for growth - Jammu Links News
What are the latest earnings results for Medicus Pharma Ltd. Equity WarrantAchieve breakthrough gains with expert advice - Jammu Links News
Is Medicus Pharma Ltd. Equity Warrant stock overvalued or undervaluedRapid growth trajectories - Jammu Links News
When is Medicus Pharma Ltd. Equity Warrant stock expected to show significant growthPhenomenal investment performance - Jammu Links News
What are analysts’ price targets for Medicus Pharma Ltd. Equity Warrant in the next 12 monthsAchieve breakthrough gains with expert advice - Jammu Links News
Is Medicus Pharma Ltd. a growth stock or a value stockAccess high-quality stock research instantly - Jammu Links News
How does Medicus Pharma Ltd. Equity Warrant compare to its industry peersInvest smarter with advanced market data - Jammu Links News
Why is Medicus Pharma Ltd. Equity Warrant stock attracting strong analyst attentionFree Consultation - Jammu Links News
How volatile is Medicus Pharma Ltd. Equity Warrant stock compared to the marketConsistently exceptional gains - Jammu Links News
Why is Medicus Pharma Ltd. stock attracting strong analyst attentionInvest confidently with professional market insights - Jammu Links News
What is the risk reward ratio of investing in Medicus Pharma Ltd. Equity Warrant stockAchieve rapid portfolio growth with expert guidance - Jammu Links News
What are the technical indicators suggesting about Medicus Pharma Ltd.Stay ahead with daily expert stock picks - Jammu Links News
How many analysts rate Medicus Pharma Ltd. as a “Buy”Achieve rapid portfolio growth with expert guidance - Jammu Links News
Medicus Pharma Ltd. Crosses 200 Day MA — Signal or NoiseBuy Alerts With Low Risk Confirmation Noted - metal.it
What institutional investors are buying Medicus Pharma Ltd. stockRetirement Planning Target Finder Backed By Experts - Jammu Links News
Does Medicus Pharma Ltd. Equity Warrant stock perform well during market downturnsDaily Trading Review That Work - Jammu Links News
How Medicus Pharma Ltd. Equity Warrant stock performs during market volatilityBuy Alerts With Low Risk Confirmation Noted - beatles.ru
Should I hold or sell Medicus Pharma Ltd. Equity Warrant stock in 2025AI Powered Tips For Every Investor - Jammu Links News
How volatile is Medicus Pharma Ltd. stock compared to the marketBeginner Investor Growth Plan Backed By Experts - Jammu Links News
Chart based analysis of Medicus Pharma Ltd. trendsSafe Entry Stock Watch Suggestions for Cautious Traders - metal.it
Marin Katusa buying at Carbon Streaming (NETZ) - The Globe and Mail
What are Medicus Pharma Ltd. Equity Warrant company’s key revenue driversWealth Building Signals From AI Tools - Jammu Links News
How Medicus Pharma Ltd. stock performs during market volatilityExpert Verified Stock Trade Ideas Backed by Data - metal.it
Published on: 2025-07-30 18:35:25 - metal.it
Medicus Pharma Appoints Deloitte for Licensing Deal - TipRanks
Medicus Pharma Ltd (MDCX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.63%
1.44%
자본화:
|
볼륨(24시간):